clobetasol propionate ophthalmic suspension 0.05% (APP13007),to the US to facilitate commercialisation. The drug, developed using Formosa's APNT nanotechnology platform, is the first US Food and ...

The FDA has issued a warning letter to Regenerative Processing Plant after conducting an inspection of the facility. The plant manufactures two ophthalmic drug products, Regener-Eyes Professional ...

SMi Group are pleased to present the 3rd Annual Ophthalmic Drugs Conference and Focus Day, taking place on the 18th-20th November 2019 in London, UK. The global ophthalmic drug market size is ...

Workshop will be on ‘Ophthalmic Drug Delivery Development - Trials and Tribulations’. Hosted by Brian Levy, CEO, Ocunexus Therapeutics. Ophthalmic Drug Delivery is compelling for many reasons ...

Report Ocean has unveiled an extensive market research report on the Ophthalmic Drugs Market industry, spanning over 150+ countries and drawing insights from more than 100,000 published and upcoming ...

Thyroid eye disease causes inflammation and damage to the tissues around the eye and most commonly occurs as part of Graves' ...

The DCGI has halted the authorization given to Mumbai-based Entod Pharmaceuticals to produce and market its novel eye drops, citing the company's assertions that it can assist individuals with ...

CAMP VICENTE LIM, Laguna, Philippines — Investigators are eyeing the possibility that a failure to remit the proceeds of a drug deal led to the killing of a food delivery rider and the shooting ...

There was no association found in infants treated with erythromycin ophthalmic ointment. Erythromycin's widely known gastrokinetic properties have been suggested as the mechanism that causes this ...